• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, April 9, 2021


Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article by HealthPayerIntelligence referenced a study published in the March 2019 issue of The American Journal of Managed Care® (AJMC®) titled “Health Insurance Literacy: Disparities by Race, Ethnicity, and Language Preference.” In the study, researchers found that compared with White enrollees in Connecticut qualified health plans, racial/ethnic minorities were disproportionately at risk for adverse health and financial consequences due to lower health insurance literacy.

A piece by FiercePharma spotlighted an article published on AJMC.com, the website of AJMC®. The article, “Cigna Dangles $500 to Persuade Patients to Switch Psoriasis Drugs,” reported that as the first quarter of 2021 ends, patients choosing to keep using secukinumab may be offered an inducement to switch to another biologic, ixekizumab. The article was also referenced by Becker’s Hospital Review.

An article by The Business Journals cited an article by AJMC®’s sister site The Center for Biosimilars®, titled “IQVIA: Biosimilars Could Save $100 Billion Over Next 5 Years.” The article covered a report from the IQVIA Institute for Human Data Science that predicts biosimilar sales of $80 billion over the next 5 years, as well as potential biosimilar-generated health care savings of more than $100 billion during that same period.

Related Videos
Michael Morse, MD, Duke Cancer Center
Screenshot of Ryan Nix, PharmD, during a video interview
Leslie Fish, PharmD.
Mila Felder, MD, FACEP
Shawn Gremminger
Dr Lucy Langer
Dr Lucy Langer
Edward Arrowsmith, MD, MPH
Dr David Fajgenbaum | Image credit: The Castleman Disease Collaborative Network
Related Content
© 2024 MJH Life Sciences
All rights reserved.